StonvexLoading…
StonvexStonvexStonvexCore line items from OMDA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $78.05M | $260.21M | $184.36M | $116.33M |
Operating Income | $-4.78M | $-11.97M | $-15.25M | $-12.74M |
Net Income | $-2.97M | $-12.78M | $-17.94M | $-5.31M |
EPS (Diluted) | $-0.05 | $-0.35 | $-0.61 | $-0.98 |
Total Assets | $302.80M | $305.41M | $287.47M | $302.97M |
Total Liabilities | $68.68M | $75.73M | $70.12M | $88.76M |
Cash & Equivalents | $211.76M | $222.04M | $198.63M | $223.15M |
Free Cash Flow OCF − CapEx | $-11.91M | $16.93M | $-4.25M | $-13.85M |
Shares Outstanding | 59.24M | 58.43M | 57.89M | 57.32M |